(Total Views: 323)
Posted On: 12/19/2019 9:46:59 AM
Post# of 145254
Thanks trding. This may have been stated elsewhere, but it's interesting that their model doesn't include oncology at all. I understand why (too remote/contingent/difficult to value), but it underscores how potentially undervalued CYDY is that someone puts a $1.50 target on CYDY without considering any indication but HIV.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)